East End Drugs

End Drug Shortages Alliance Recommends Specific Actions to Mitigate Drug Shortages in Wake of Damage to Pfizer Plant in North Carolina

Retrieved on: 
Friday, July 21, 2023
Biotechnology, Pharmaceutical, Medical Supplies, General Health, Health, Medical Devices, Hospitals, Other Health, Rocky, System, Therapy, East End Drugs, Group purchasing organization, Anesthesia, Pain, Hospital, Patient, FDA, Organization, Pharmaceutical industry, Medical device, Nursing

The plant was both a production facility and a warehouse for finished products including anesthesia, analgesia, therapeutics, anti-infectives and neuromuscular blocker product categories.

Key Points: 
  • The plant was both a production facility and a warehouse for finished products including anesthesia, analgesia, therapeutics, anti-infectives and neuromuscular blocker product categories.
  • Pfizer’s website currently states that 200 million units are shipped globally every year from their Rocky Mount facility.
  • The U.S. Food & Drug Administration (FDA) is encouraged to expedite the review and evaluation of the impacted plant.
  • Organizations interested in joining the End Drug Shortages Alliance to collaborate and support patients during a disruption by being stewards of supply can learn more here: https://www.enddrugshortages.com/ .

End Drug Shortages Alliance Releases Report for Drugs Impacted by Pharmaceutical Plant Closure

Retrieved on: 
Wednesday, March 15, 2023
Other Manufacturing, Medical Supplies, Hospitals, Transport, Manufacturing, Practice Management, General Health, Pharmaceutical, Health, Logistics, Supply Chain Management, Oklahoma Hospital Association, Risk, Dimercaprol, Hyperparathyroidism, Supraventricular tachycardia, ASHP, Patient, EDSA, Calcitriol, Organic acid, Knowledge, Akorn, Physostigmine, East End Drugs, Bankruptcy, Adenosine, CHA, Anticholinergic, Mayo Clinic, Kidney, Pharmaceutical industry, Risk management, Medical device, Nursing, Vizient, Inc.

The End Drug Shortages Alliance (EDSA) today released a report assessing the impact to the U.S. market caused by the recent closure of a drug manufacturer.

Key Points: 
  • The End Drug Shortages Alliance (EDSA) today released a report assessing the impact to the U.S. market caused by the recent closure of a drug manufacturer.
  • “Transparency regarding drug shortages is important to ensure patient care remains uninterrupted,” said Mittal Sutaria, senior vice president, Vizient pharmacy contract and program services and EDSA board member.
  • Clinicians and providers, to exercise a stewardship mindset and review purchasing and formulary status to determine conservation and mitigation strategies.
  • “Advance knowledge of supply disruptions is part of the transparency that the End Drug Shortages Alliance has advocated for since forming.

End Drug Shortages Alliance Finds Care for Bladder Cancer Patients Impacted by Drug Shortage

Retrieved on: 
Wednesday, February 15, 2023
Biotechnology, Health, Manufacturing, Other Health, Pharmaceutical, Transport, Oncology, Practice Management, Hospitals, Communications, Other Manufacturing, Social Activism, Logistics, Supply Chain Management, Medical Supplies, MBA, American Urological Association, Urinary bladder, Docetaxel, Mayo Clinic, American Society of Health-System Pharmacists, Maintenance, Patient, EDSA, Incidence, AUC, Doctor of Pharmacy, Bladder cancer, Mitomycins, FCCP, NMIBC, Bacillus, National Comprehensive Cancer Network, Society, BCG, East End Drugs, Death, Nursing, Dietary supplement, Vaccine, Vizient, Inc.

The End Drug Shortages Alliance (EDSA) today released a white paper that describes the ongoing gap in supply and anticipated future demand of Bacillus Calmette-Guerin (BCG), an essential oncology medication used to treat patients with bladder cancer.

Key Points: 
  • The End Drug Shortages Alliance (EDSA) today released a white paper that describes the ongoing gap in supply and anticipated future demand of Bacillus Calmette-Guerin (BCG), an essential oncology medication used to treat patients with bladder cancer.
  • Approximately 82,000 cases of bladder cancer are diagnosed in the U.S. every year, with approximately 17,000 deaths.
  • “The standard of care for bladder cancer patients is being compromised,” said Eric Tichy, PharmD, MBA, FCCP, division chair, pharmacy supply solutions for Mayo Clinic and EDSA chairperson.
  • The End Drug Shortages Alliance calls on pharmaceutical manufacturers to investigate increased manufacturing of BCG to end the shortage and ensure delivery of care to all bladder cancer patients.

Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance

Retrieved on: 
Wednesday, June 29, 2022
Medical Devices, Medical Supplies, Hospitals, Biotechnology, Other Health, Managed Care, Health, Pharmaceutical, General Health, Health, East End Drugs, Patient, CEO, Biotechnology, Industry, Mayo Clinic, Organization, Quality of life, Medication, Pharmaceutical industry, Risk management, Amr Al-Dabbagh, Alliance

Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today it has joined The End Drug Shortages Alliance (Alliance), a new coalition of diverse stakeholders to address drug shortages in the United States.

Key Points: 
  • Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today it has joined The End Drug Shortages Alliance (Alliance), a new coalition of diverse stakeholders to address drug shortages in the United States.
  • Drug shortages continue to impact health care and its delivery, said Daniel Carbery, President and CEO of Amring.
  • As a member of Alliance, we will work together to develop collaborative mitigation strategies to address issues contributing to these shortages.
  • "We are grateful to have Amring join Alliance to end drug shortages," said Eric Tichy, Division Chair of Pharmacy Supply Solutions for Mayo Clinic, who serves as the Chair for the Alliance advisory board.

Leiters, a WCAS Portfolio Company, Joins the End Drug Shortages Alliance

Retrieved on: 
Wednesday, June 29, 2022
Health, FDA, East End Drugs, Patient, CEO, CGMP, Good manufacturing practice, FD, Evolutionary models of human drug use, Industry, Mayo Clinic, Organization, Quality of life, Alliance, IV, Hospital, Medical device, Pharmaceutical industry, Michael Leiter

The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of health care's more pressing and enduring issues, drug shortages that disrupt patient care.

Key Points: 
  • The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of health care's more pressing and enduring issues, drug shortages that disrupt patient care.
  • "Drug shortages impact the delivery of critical medicines and the delivery of patient care," said Robin Smith Hoke, President and CEO of Leiters.
  • "As a member of the alliance, we will work collaboratively across the supply chain to develop strategies to address factors that contribute to these shortages."
  • The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions.

Zydus Pharmaceuticals (USA) Inc. joins the End Drug Shortages Alliance

Retrieved on: 
Wednesday, June 29, 2022
Health, East End Drugs, Patient, CEO, Stock, Prescription, National, Industry, Mayo Clinic, Organization, Quality of life, MAT, IQVIA, Solution, Freedom, Medicine, Pharmaceutical industry

The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare's more pressing and enduring issues, drug shortages that disrupt patient care.

Key Points: 
  • The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare's more pressing and enduring issues, drug shortages that disrupt patient care.
  • "Drug shortages continue to impact patients and their families," said Michael Keenley, CEO, Zydus Pharmaceuticals (USA) Inc. "As a member of the alliance, we will work to develop strategies within the coalition to address the issues contributing to drug shortages."
  • "We are happyto have Zydus Pharmaceuticals join the alliance to end drug shortages," said Eric Tichy, Division Chair of Pharmacy Supply Solutions for Mayo Clinic, who serves as the Chair for the Alliance Advisory Board.
  • About Zydus Pharmaceuticals (USA) Inc.
    Zydus Pharmaceuticals (USA) Inc. is the US generic drug division of Zydus Lifesciences Ltd. Over the past 17 years, Zydus Pharmaceuticals has been committed to providing quality, innovation, and service.

OrbitalRX Joins End Drug Shortages Alliance

Retrieved on: 
Wednesday, June 29, 2022
Other Health, Software, Supply Chain Management, General Health, Other Retail, Pharmaceutical, Data Management, Specialty, Technology, Hospitals, Retail, Health, Health, Patient, MS, East End Drugs, Industry, Doctor of Pharmacy, Mayo Clinic, Organization, Quality of life, Â, Risk, Alliance, Hospital, Medicine

The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of health cares more pressing and enduring issues, drug shortages that disrupt patient care.

Key Points: 
  • The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of health cares more pressing and enduring issues, drug shortages that disrupt patient care.
  • By joining the End Drug Shortages Alliance, we can work with hospitals and experts across the country to increase supply chain transparency and find meaningful ways to manage the drug supply.
  • The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions.
  • "We are grateful to have OrbitalRX join the alliance to end drug shortages," said Eric Tichy, division chair of pharmacy supply solutions for Mayo Clinic, who serves as the Chair for the Alliance advisory board.

RISCS, Inc. Joins End Drug Shortages Alliance

Retrieved on: 
Wednesday, June 29, 2022
Supply Chain Management, Retail, Health, Hospitals, Other Health, Pharmaceutical, Health, East End Drugs, Patient, Industry, Certification, Mayo Clinic, Organization, Quality of life, Alliance, EDSA, Medicine, Pharmaceutical industry

The End Drug Shortages Alliance (EDSA) provides a forum for key stakeholders to take strategic aim at one of health cares more pressing and enduring issues, drug shortages that disrupt patient care.

Key Points: 
  • The End Drug Shortages Alliance (EDSA) provides a forum for key stakeholders to take strategic aim at one of health cares more pressing and enduring issues, drug shortages that disrupt patient care.
  • We are excited to announce our membership in the End Drug Shortages Alliance and my appointment to the EDSA Board of Directors , said Stephen Colvill, Executive Director of RISCS.
  • The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions.
  • "We are grateful to have RISCS join the alliance to end drug shortages," said Eric Tichy, division chair of pharmacy supply solutions for Mayo Clinic, who serves as the Chair for the Alliance advisory board.

End Drug Shortages Alliance Releases Market Assessment for Drugs Impacted by Manufacturing Plant Closure

Retrieved on: 
Tuesday, May 17, 2022
Other Manufacturing, Medical Supplies, Hospitals, Transport, Manufacturing, Practice Management, Health, Pharmaceutical, Logistics, Supply Chain Management, Diabetes, Risk, Teva, Patient, Solution, Adult, Pharmacy, Media, Oklahoma Hospital Association, Industry, Organization, Pancreatic neuroendocrine tumor, Cancer, CMTM, East End Drugs, Pharmaceutical industry, Risk management, Medicine, Alliance

The End Drug Shortages Alliance today announced it has released a market analysis of products affected by a recent Teva pharmaceutical manufacturing plant closure in Irvine, Calif.

Key Points: 
  • The End Drug Shortages Alliance today announced it has released a market analysis of products affected by a recent Teva pharmaceutical manufacturing plant closure in Irvine, Calif.
  • Information shared in this report highlights the level of transparency that is required across the supply chain to successfully navigate drug shortages.
  • All Alliance workstreams are aligned to the organizations objectives, including:
    Transparency and redundancy, including an early alert system for drug shortages.
  • To learn more about the End Drug Shortages Alliance, email [email protected] .

End Drug Shortages Alliance Announces Board of Directors, Mission, Vision Statements in First All-Member Meeting

Retrieved on: 
Tuesday, May 3, 2022
Practice Management, Pharmaceutical, Medical Supplies, General Health, Health, Hospitals, Supply Chain Management, Retail, Board, Communication, Senior, ASHP, CMTM, Assistant professor, American Pharmacists Association, MS, Mayo Clinic, Patient, Doctor of Philosophy, Association, Organization, Program, Pharmacist, Industry, FCCP, MD, Oklahoma Hospital Association, East End Drugs, Alliance, MBA, Vizient, Inc., Solution, CEO, JD, American, Doctor of Pharmacy, Risk, Management, Medicine, Medical device, Pharmacy

"The Alliance has generated a lot of excitement from across the industry for resolving the persistent issue of drug shortages," said Tichy.

Key Points: 
  • "The Alliance has generated a lot of excitement from across the industry for resolving the persistent issue of drug shortages," said Tichy.
  • The End Drug Shortages Alliance was launched in November to address the ongoing crisis and more than 70 organizations have joined to date.
  • Collectively we will end drug shortages through focus on transparency, communication, quality, redundancy and production of additional supply to achieve measurable and sustainable results.
  • The outpouring of support for the End Drug Shortages Alliance throughout the industry has been tremendous, said Mittal Sutaria, Vizient senior vice president, pharmacy contract and program solutions and End Drug Shortages Alliance board member.